These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37369465)

  • 1. Reduced Production of JAK2V617F-positive Microparticles at Mild Hypothermia.
    Hekimoglu H; Demirtas EN; Sozer S
    In Vivo; 2023; 37(4):1680-1687. PubMed ID: 37369465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles.
    Hekimoğlu H; Toprak SF; Sözer S
    Turk J Haematol; 2022 Feb; 39(1):13-21. PubMed ID: 34981912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.
    Castiglione M; Jiang YP; Mazzeo C; Lee S; Chen JS; Kaushansky K; Yin W; Lin RZ; Zheng H; Zhan H
    J Thromb Haemost; 2020 Dec; 18(12):3359-3370. PubMed ID: 32920974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD133+/–CD34– Have Increased c-
    Uslu Bıçak İ; Tokcan B; Yavuz AS; Tokdemir SS
    Turk J Haematol; 2023 Feb; 40(1):28-36. PubMed ID: 36458557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.
    Mazzeo C; Quan M; Wong H; Castiglione M; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2021 Sep; 90():102585. PubMed ID: 34139651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.
    Etheridge SL; Roh ME; Cosgrove ME; Sangkhae V; Fox NE; Chen J; López JA; Kaushansky K; Hitchcock IS
    Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2295-300. PubMed ID: 24469804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
    Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
    Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
    Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
    Shock; 2015 May; 43(5):443-9. PubMed ID: 25608138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-angiogenic effect of interferon on JAK2V617F positive myeloproliferative neoplasms and its anti-angiogenic mechanisms].
    Fu J; Xu Q; Zhao Y; Liu G; Cheng Z; Liang W; Xie X; Gu L
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(46):3727-32. PubMed ID: 26850010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
    Kaushansky K; Zhan H
    Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
    Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R
    J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.
    Zhan H; Lin CHS; Segal Y; Kaushansky K
    Leukemia; 2018 Feb; 32(2):462-469. PubMed ID: 28744010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features.
    Guadall A; Lesteven E; Letort G; Awan Toor S; Delord M; Pognant D; Brusson M; Verger E; Maslah N; Giraudier S; Larghero J; Vanneaux V; Chomienne C; El Nemer W; Cassinat B; Kiladjian JJ
    Thromb Haemost; 2018 Sep; 118(9):1586-1599. PubMed ID: 30103245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms.
    Arı MC; Büyüktaş D; Eşkazan AE; Ongören Aydın S; Tanrıkulu E; Başlar Z; Buyru AN; Ferhanoğlu B; Aydın Y; Tüzüner N; Soysal T
    Turk J Haematol; 2012 Sep; 29(3):242-7. PubMed ID: 24744667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating microparticles in Ph
    Zhang W; Qi J; Zhao S; Shen W; Dai L; Han W; Huang M; Wang Z; Ruan C; Wu D; Han Y
    Oncol Lett; 2017 Aug; 14(2):2531-2536. PubMed ID: 28789461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].
    Li MY; Chao HY; Sun AN; Qiu HY; Jin ZM; Tang XW; Han Y; Fu CC; Chen SN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):295-300. PubMed ID: 28468090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Level of Microparticles in Patients with Essential Thrombocythemia and Its Relation with JAK2V617F Mutation].
    Zhao SX; Yang TH; Pei Q; Zhao RB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2046-2050. PubMed ID: 33283740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
    Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
    Sun T; Zhang L
    Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
    Zhao B; Mei Y; Cao L; Zhang J; Sumagin R; Yang J; Gao J; Schipma MJ; Wang Y; Thorsheim C; Zhao L; Stalker T; Stein B; Wen QJ; Crispino JD; Abrams CS; Ji P
    J Clin Invest; 2018 Jan; 128(1):125-140. PubMed ID: 29202466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.